Current European guidelines for the management of heart failure recommend the use of risk scores. Among these, the MECKI score (Metabolic Exercise Test Data Combined with Cardiac and Kidney Indexes) has proven to be one of the most accurate. Nevertheless, risk scores are poorly used in clinical practice, in part because there is a lack of strong evidence to support their external validation in diverse populations.
This content is machine-translated. Please contact us if you need professional translation services.
Autoren
- Isabell Bemfert
Publikation
- CARDIOVASC
Related Topics
You May Also Like
- Coronary heart disease and type 2 diabetes
Relationship between baseline FFA values and all-cause mortality.
- Esophagus
Therapy of esophageal carcinoma – an overview
- Visceral Surgery Update - Part 1
Upper gastrointestinal tract and robotic visceral surgery
- Case reports: Pityriasis rubra pilaris (PRP)
Supposedly therapy-resistant PRP responded to biologic treatment
- Polyneuropathies
Disorders of brain, spinal cord and nerve function
- Pulmonary arterial hypertension beyond the guideline.
IPAH or what else? – IPAH with pulmonary comorbidity
- Disease of the subcutaneous adipose tissue
Lipedema – a painful fatty tissue disease of the extremities in women
- Rare diseases